Hsu Jason - Insider Non-Derivative Transactions at Immix Biopharma, Inc. (IMMX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 22, 2024, Hsu Jason's relationship to Immix Biopharma, Inc. (IMMX) is Director, and currently has 845,300 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other IMMX insiders.
Data Source: SEC.
Hsu Jason - Insider Non-Derivative Transactions of IMMX Common Stock
Hsu Jason - Insider Non-Derivative Transactions at IMMX
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Aug 23, 2024 | P -- (Common Stock) | 8100 | 2.25 | 845300 |
Aug 22, 2024 | P -- (Common Stock) | 15000 | 2.23 | 837200 |
Jul 25, 2024 | P -- (Common Stock) | 6000 | 2.15 | 822200 |
Jul 19, 2024 | P -- (Common Stock) | 3200 | 2.07 | 816200 |
Dec 12, 2023 | P -- (Common Stock) | 31000 | 4.67 | 813000 |
Dec 9, 2023 | P -- (Common Stock) | 25000 | 4.88 | 782000 |
Sep 16, 2023 | P -- (Common Stock) | 7000 | 2.49 | 757000 |
Sep 15, 2023 | P -- (Common Stock) | 10000 | 2.58 | 750000 |
Sep 13, 2023 | P -- (Common Stock) | 30000 | 2.83 | 740000 |
Sep 12, 2023 | P -- (Common Stock) | 25000 | 2.89 | 710000 |
Sep 9, 2023 | P -- (Common Stock) | 10000 | 2.53 | 685000 |